OP0190 NEUROIMMUNE MODULATION FOR TREATMENT OF RHEUMATOID ARTHRITIS IN ADULTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL OR TARGETED SYNTHETIC DMARDs: RESULTS AT 12 AND 24 WEEKS FROM A RANDOMIZED, SHAM-CONTROLLED, DOUBLE-BLIND STUDY (RESET-RA STUDY) (Annals of the rheumatic diseases)